Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Magnus Ingelman-Sundberg

28PUBLICATIONS

51CO-AUTHORS

Electrochemical energy storage and conversionPharmacogenomicsMolecular targetsClinical pharmacology and therapeuticsCheminformatics and quantitative structure-activity relationships

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|Oct 11, 2025

Dietary-Driven Gene Expansion.

Magnus Ingelman-Sundberg

|Apr 22, 2025

Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account.

Inger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou

|Feb 06, 2025

The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model.

Jan Dusek, Ivana Mejdrová, Klára Dohnalová

|Oct 16, 2024

The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet-Examples of Recent Accomplishments and Future Perspectives.

Eddie Weitzberg, Magnus Ingelman-Sundberg, Jon O Lundberg

|Aug 05, 2024

Pharmacogenomic Prescribing Guidelines: Are They Always Useful?

Magnus Ingelman-Sundberg

|Apr 04, 2024

Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and Treatment.

Magnus Ingelman-Sundberg, Volker M Lauschke

Pageof 5

Frequent Collaborators

7 joint publications

Espen Molden

5 joint publications

Volker M Lauschke

4 joint publications

Marin M Jukić

4 joint publications

Robert Løvsletten Smith

4 joint publications

Inger Johansson

3 joint publications

Chris S Pridgeon

3 joint publications

Birgit M Wollmann

3 joint publications

Hasan Çağın Lenk

2 joint publications

Jesse J Swen

2 joint publications

Katharina Klöditz

Frequent Collaborators

7 joint publications

Espen Molden

5 joint publications

Volker M Lauschke

4 joint publications

Marin M Jukić

4 joint publications

Robert Løvsletten Smith

Top Related Videos

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in <em>C. elegans</em>

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in <em>C. elegans</em>

Published on : Aug 16, 2017

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on : Mar 29, 2024

See more related videos

Top Related Videos

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in <em>C. elegans</em>

Quantification of Information Encoded by Gene Expression Levels During Lifespan Modulation Under Broad-range Dietary Restriction in <em>C. elegans</em>

Published on : Aug 16, 2017

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of <em>In Vitro</em> Cell Cultures

Published on : Mar 28, 2017

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on : Mar 29, 2024

See more related videos